Achieving chronic hepatitis B functional cure: Factors and potential mechanisms
Chronic hepatitis B (CHB) is a significant global health issue affecting approximately 254 million individuals worldwide. Achieving the loss of hepatitis B surface antigen (HBsAg), either with or without seroconversion to hepatitis B surface antibody (HBsAb), is regarded as a functional cure and the...
Saved in:
Main Authors: | Jiarui Zheng, Zilong Wang, Linxiang Huang, Zixuan Qiu, Yandi Xie, Suzhen Jiang, Bo Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0168170224002004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring using HBsAg to predict interferon treatment course to achieve clinical cure in chronic hepatitis B patients: a clinical study
by: Fei Yan, et al.
Published: (2025-01-01) -
Predictive factors for clinical cure in the treatment of HBeAg(−) chronic hepatitis B or compensated cirrhosis: a prospective observational study
by: Yan-Qing Lv, et al.
Published: (2025-01-01) -
Correlation Between Clinical Indicators and Liver Pathology in Children with Chronic Hepatitis B
by: Chenyang Huang, et al.
Published: (2024-12-01) -
The salivary microbiome and oral health status in HBeAg-negative chronic hepatitis B
by: Liyan Lu, et al.
Published: (2024-12-01) -
Immune response to occult hepatitis B virus infection among hemodialysis patients: A review
by: Ali Mussa, et al.
Published: (2024-12-01)